A phase II study of Capecitabine (Xeloda) in the treatment of ovarian cancer resistant or refractory to platinum therapy: MITO-6 trial Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, March 07, 2009

A phase II study of Capecitabine (Xeloda) in the treatment of ovarian cancer resistant or refractory to platinum therapy: MITO-6 trial



negative results trial finding
Blogger

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )